Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 2Phase 3 2Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 11Unknown 3Terminated 2Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Non-small Cell Lung Cancers 1Fibrosis 1Breast Cancer Female 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Pentoxifylline × Clear all
NCT06176339 2024-03-15

Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients"

Mansoura University

Phase 2 Unknown
70 enrolled
Breast

Breast Cancer Female

NCT01871454 2024-02-07

Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers

University of Louisville

Phase 2 Unknown
59 enrolled
Thoracic

Non-small Cell Lung Cancers

NCT01822405 2013-04-02

ORT-OXI-2009

Hospital Universitario de Canarias

Phase 2 Unknown
42 enrolled

Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡